USPTO trademark

Crinetics Pharmaceuticals, Inc design mark 50184293

Under examinationUSPTOFigurative markClass 9Class 41Class 44Class 45

"Design mark 50184293" is a figurative mark owned by Crinetics Pharmaceuticals, Inc., filed at the USPTO on October 27, 2026. It is under examination and covers classes 9, 41, 44 and 45.

View Crinetics Pharmaceuticals, Inc. portfolioGet this data via the API
Official USPTO record
Crinetics Pharmaceuticals, Inc design mark 50184293 trademark as filed
As filed with the USPTO
Status
Under examination
Since October 27, 2026
Filed
October 27, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50184293
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Figurative mark
4 classes
Ownership

Who owns Crinetics Pharmaceuticals, Inc design mark 50184293

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Crinetics Pharmaceuticals, Inc.

CRNX · San Diego, United States

63 trademarks in the portfolioView company

Representative

Danny M. Awdeh

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Goods and services

What the mark covers

The products and services Crinetics Pharmaceuticals, Inc design mark 50184293 is filed for, grouped by Nice class.

  • Downloadable mobile application software for patients with endocrine and endocrine-related conditions for recording, tracking, graphing, and monitoring symptoms, generating alerts regarding changes in symptom severity, providing educational information in the fields of endocrine and endocrine-related conditions and disease management, and generating symptom reports for sharing with healthcare providers

  • Educational services, namely, conducting workshops, seminars, and classes in the field of endocrine and endocrine-related conditions, disease management, and patient self-advocacy, and distribution of training materials in connection therewith; Arranging, organizing, and conducting educational events, namely, workshops and seminars, for patients with endocrine diseases and endocrine-related conditions and their caregivers on the subject of endocrine diseases and endocrine-related conditions; Providing online non-downloadable publications in the nature of articles, guides, fact sheets, and newsletters in the fields of endocrine diseases and endocrine-related conditions, disease management, and patient self-advocacy; Providing online non-downloadable webinars and videos in the fields of endocrine disease and endocrine-related conditions, disease management, and patient self-advocacy

  • Providing health and medical information in the fields of endocrine diseases and endocrine-related conditions, disease management, symptom management, and mental and emotional health of patients with endocrine diseases and endocrine-related conditions via a website and mobile application; Providing a website featuring health and medical information and links to third-party resources in the fields of endocrine diseases and endocrine-related conditions, and treatment of endocrine and endocrine-related conditions; Providing health and medical information regarding healthcare providers

  • Organizing and conducting support groups in the field of endocrine diseases and endocrine-related conditions for patients and their caregivers; Providing personal support services for patients with endocrine and endocrine-related conditions and their caregivers, namely, providing emotional support and assistance in the nature of patient self-advocacy

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application entered
FAQ

About Crinetics Pharmaceuticals, Inc design mark 50184293

Who owns the trademark "Design mark 50184293"?

The USPTO trademark "Design mark 50184293" (application 50184293) is owned by Crinetics Pharmaceuticals, Inc.

What is the status of "Design mark 50184293"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Crinetics Pharmaceuticals, Inc design mark 50184293 and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a1829f-4678-716e-b24d-e4806f3f2a59
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a1829f-4678-716e-b24d-e4806f3f2a59",
  "object": "trademark",
  "mark_text": "[Design Mark]",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50184293",
  "filing_date": "2026-10-27",
  "nice_classes": [
    9,
    41,
    44,
    45
  ],
  "owners": [
    {
      "name": "Crinetics Pharmaceuticals, Inc.",
      "entity_id": "ent_019ebbf8-aad0-7313-af9b-0ea77adc1cc3"
    }
  ]
}